Andrew Makrides - Jul 5, 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Director
Signature
/s/ Andrew Makrides
Stock symbol
APYX
Transactions as of
Jul 5, 2022
Transactions value $
-$7,200
Form type
4
Date filed
7/11/2022, 03:54 PM
Previous filing
Aug 11, 2021
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APYX Common Stock Options Exercise $76.2K +30K +4.93% $2.54 638K Jul 5, 2022 Direct
transaction APYX Common Stock Tax liability -$83.4K -13.6K -2.13% $6.14 624K Jul 5, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Options Exercise $0 -30K -100% $0.00* 0 Jul 5, 2022 Common Stock 30K $2.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock options.
F2 Reporting Person was granted a stock option that vested and became exercisable over 5 years at a rate of 20% of the option on the anniversary date of each year.